1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. GYRE THERAPEUTICS INC
Gyre Therapeutics Inc XNAS: GYRE
7.58 -0.50 (-6.19%)
70,184
XNAS Volume

XNAS 04 Sep, 2025 5:30 PM (EDT)

Gyre Therapeutics Inc - GYRE - stock price prediction, stock price target, analyst ratings from 2 analysts

Gyre Therapeutics Inc has a share price target of US$ 19, revenue growth forecast of 16.1%, and profit growth estimate of 43.1% for FY25, based on top 2 analyst calls.